CJC-1295 [no DAC] + IPA

This research blend pairs CJC-1295 without DAC, a short-acting GHRH receptor agonist that stimulates pulsatile growth hormone release via the pituitary somatotroph cAMP cascade, with Ipamorelin, a selective pentapeptide agonist of the ghrelin/growth hormone secretagogue receptor (GHSR-1a). The two compounds operate through distinct but convergent receptor pathways — GHRH-R and GHSR-1a respectively — and research has examined their combined use as a model for synergistic amplification of GH pulses. Ipamorelin’s documented selectivity, including minimal co-stimulation of ACTH or cortisol, makes this blend of particular interest in studies designed to isolate GH axis effects from broader corticotropic confounders. Supplied as co-lyophilized powder, ≥99% purity. Store at -20°C. Research use only. Not for human consumption.